Solving Scoliosis Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 235.80%
- Profit Growth 55627.60%
- Ebitda 666.52%
- Net Worth 279.03%
- Total Assets 139.69%
About Solving Scoliosis
Solving Scoliosis Private Limited (SSPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 April 2018 (Six years and ten months 9 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aditi Watve and Shridhar Chiplunkar serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300PN2018PTC176138
- Company No.
176138
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Solving Scoliosis?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditi Watve  | Director | 19-Apr-2018 | Current |
| Shridhar Chiplunkar | Director | 19-Apr-2018 | Current |
Financial Performance of Solving Scoliosis.
Solving Scoliosis Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 235.8% increase. The company also saw a substantial improvement in profitability, with a 55627.6% increase in profit. The company's net worth Soared by an impressive increase of 279.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solving Scoliosis?
Unlock access to Solving Scoliosis's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sakha Solutions LlpAditi Watve is a mutual person
- New Lohit Pharma Llp
Aditi Watve is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Solving Scoliosis?
Unlock and access historical data on people associated with Solving Scoliosis, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solving Scoliosis, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solving Scoliosis's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.